Invesco Ltd. Eli Lilly & CO Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Invesco Ltd. holds 3,149,321 shares of LLY stock, worth $2.85 Billion. This represents 0.54% of its overall portfolio holdings.

Number of Shares

3,149,321

Previous 3,067,172 2.68%

Holding current value

$2.85 Billion

Previous $1.79 Billion 37.03%

% of portfolio

0.54%

Previous 0.43%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $48.6 Million - $65.1 Million	82,149 Added 2.68%	3,149,321 $2.45 Billion
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $100 Million - $118 Million	-190,873 Reduced 5.86%	3,067,172 $1.79 Billion
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $303 Million - $418 Million	-697,608 Reduced 17.64%	3,258,045 $1.75 Billion
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $25.8 Million - $34.5 Million	-73,484 Reduced 1.82%	3,955,653 $1.86 Billion
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $34.1 Million - $40 Million	-109,689 Reduced 2.65%	4,029,137 $1.38 Billion

Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $231 Million - $269 Million	-717,500 Reduced 14.77%	4,138,826 $1.51 Billion
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $17.2 Million - $19.6 Million	57,969 Added 1.21%	4,856,326 $1.57 Billion
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.79 Million - $2.1 Million	6,419 Added 0.13%	4,798,357 $1.56 Billion
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $113 Million - $141 Million	-482,716 Reduced 9.15%	4,791,938 $1.37 Billion
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $54.5 Million - $67.6 Million	242,241 Added 4.81%	5,274,654 $1.46 Billion
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $157 Million - $193 Million	-707,723 Reduced 12.33%	5,032,413 $1.16 Billion
Q2 2021 Aug 17, 2021	SELL	$180.55 - $233.54 $60.6 Million - $78.4 Million	-335,617 Reduced 5.52%	5,740,136 $1.32 Billion
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $63.2 Million - $81.8 Million	-384,766 Reduced 5.96%	6,075,753 $1.14 Billion
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $249 Million - $329 Million	1,907,345 Added 41.89%	6,460,519 $1.09 Billion
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $42.6 Million - $49.3 Million	-291,280 Reduced 6.01%	4,553,174 $674 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $83.9 Million - $101 Million	-615,095 Reduced 11.27%	4,844,454 $795 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $37.8 Million - $46.8 Million	317,893 Added 6.18%	5,459,549 $757 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $45.2 Million - $56 Million	422,989 Added 8.96%	5,141,656 $676 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $36.7 Million - $39.9 Million	-343,361 Reduced 6.78%	4,718,667 $528 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $34.7 Million - $40.5 Million	-312,967 Reduced 5.82%	5,062,028 $561 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $148 Million - $174 Million	-1,328,740 Reduced 19.82%	5,374,995 $697 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $710 Million - $795 Million	6,703,735 New	6,703,735 $776 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account